Skip to main content

Table 1 Comparison between the study groups (I and II) as regards demographic, clinical, and laboratory data at baseline

From: Diagnostic accuracy of serum endothelin-1 in patients with HCC on top of liver cirrhosis

  Group I
n = 30
Group II
n = 30
P value
HBV 6.7% 0.0% 0.31
HCV 80.0% 80.0% 1.00
Unknown 13.3% 20.0% 0.62
DM 16.7% 13.4% 0.76
Hypertension 16.7% 23.4% 0.67
History of ascites 70.0% 50.0% 0.36
History of lower limb edema 80.0% 50.0% 0.16
Abdominal pain 46.7% 10.0% 0.06
Abdominal tenderness 10.0% 10.0% 1.00
Bleeding tendency 56.7% 53.3% 0.71
History of GIT bleeding 36.7% 40.0% 0.79
History of hepatic encephalopathy 53.3% 46.7% 0.61
Clinical presence of hepatic encephalopathy 73.3% 60.0% 0.71
Hb (mean ± SD) 10.82 ± 2.43 9.16 ± 2.85 0.09
WBCs (mean ± SD) 7.70 ± 3.76 6.25 ± 4.14 0.23
Platelets (mean ± SD) 143.40 ± 67.63 93.70 ± 80.59 0.03
Albumin (g/dl) 2.8 ± 0.7 2.6 ± 0.5 0.10
Total bilirubin (mg/dl) 3.14 ± 2.9 3.5 ± 3.7 0.61
ALT (IU/l) 68.3 ± 20.2 65.5 ± 20 0.21
AST (IU/l) 54.2 ± 15.8 48.1 ± 8 0.18
PT (s) 16.8 ± 6.7 16.6 ± 1.8 0.83
Creatinine (mg/dl) 1.6 ± 0.9 1.8 ± 0.9 0.71
P.V.T 26.7% 0.0% NA
Metastasis 0.0% 0.0% NA
  1. Bold values indicate significance
  2. There was no statistically significant difference between groups I & II as regards demographic, clinical, and laboratory data at baseline